Research Article

Clinical Efficacy and Safety of Stem Cell-Based Therapy in Treating Asherman Syndrome: A System Review and Meta-Analysis

Table 2

Characters of stem cell-based therapy in treating AS syndrome.

Authors/yearCell sourceTransplant cell typeCell number (106)Transplanted sectionHTFollow up (months)

Singh et al. 2014Bone marrowMononuclear stem cellsSubendometrial transmyometrium injection
(fundus, anterior, posterior)
Oral estradiol valerate, 6 mg/day (12 weeks). Medroxy progesterone (last 10 days).
Patients (started menstruation): Shifted to cyclical oral estrogen valerate 2 mg (tid, day 1 to day 26), progesterone 10 mg daily (day 16 to day 25).
9

Santamaria et al. 2016Per blood mobilizationCD133+ bone marrow
Derived stem cells
123.6Infusion into spiral arteriolesHormonal replacement therapy (Progyluton™)6

Tan et al. 2016Menstrual bloodMenstrual blood
Derived stromal cells
106 (5 patients),
(2 patients)
Instill into uterus fundusMenSCs collection (day 5), oestradiol (4 mg, 14 day). MenSCs transplant, oestradiol (6 mg, 21 day).
: progesterone injection 40 mg.
6

Zhao et al. 2016Bone marrowBM-mononuclear stem cells loaded in collagen scaffold scaffold
( cm2)
Attach to the uterine wallProgynova (6 mg, 10 days), operation, continuous Progynova (6 mg, 30 days), progesterone injection (60 mg, 30th day)3

Cao et al. 2018Umbilical cordUmbilical cord-derived
Mesenchymal stromal cells
10Attach to the uterine wallProgynova (6 mg, 10 days), operation, continuous Progynova (6 mg, 30 days), progesterone injection (60 mg, 30th day)30

Lee et al. 2019Adipose tissueAdipose-derived MSCs loaded in stromal vascular fraction4.6Cervical instillationOral estradiol valerate (6 mg, day1 to day 25),
Oral Medroxyprogesterone
(10 mg, day 21 to day 25)
23

Singh et al. 2020Bone marrowBM-mononuclear stem cellsSubendometrial transmyometrium injection
(fundus, anterior, posterior)
Oral estradiol valerate (2 mg, Tid,12 weeks), : Medroxyprogesterone
(10 mg, last 10 days in 12 week)
: additional cycle.
60

Ma et al. 2020Menstrual bloodMenstrual blood stem
Cells (MenSCs)
10EndometriumOral estradiol (2 mg, Tid, 14 days)
+ additional 3 days()
NA

AS: Asherman syndrome; G-CSF: granulocyte colony-stimulating factor; BM: bone marrow; Tid: three times daily; ET: endometrium thickness.